BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 11677996)

  • 21. [Clinicopathological analysis of synchronous liver metastasis in gastric cancer and evaluation of surgical outcomes].
    Li YM; Zhan WH; Han FH; He YL; Peng JS; Cai SR; Ma JP; Zhao G
    Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Mar; 9(2):127-30. PubMed ID: 16555151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significance of para-aortic lymph node dissection in advanced gastric cancer.
    Kunisaki C; Shimada H; Yamaoka H; Wakasugi J; Takahashi M; Akiyama H; Nomura M; Moriwaki Y
    Hepatogastroenterology; 1999; 46(28):2635-42. PubMed ID: 10522056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical treatment for gastric carcinomas with concomitant hepatic metastasis.
    Saito A; Korenaga D; Sakaguchi Y; Ohno S; Ichiyoshi Y; Sugimachi K
    Hepatogastroenterology; 1996; 43(9):560-4. PubMed ID: 8799395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of the prognostic factors for liver metastasis of gastric cancer after hepatic resection: a multi-institutional study of the indications for resection.
    Shirabe K; Shimada M; Matsumata T; Higashi H; Yakeishi Y; Wakiyama S; Ikeda Y; Ezaki T; Fukuzawa S; Takenaka K; Kishikawa K; Ikeda T; Taguchi K; Maehara Y; Sugimachi K
    Hepatogastroenterology; 2003; 50(53):1560-3. PubMed ID: 14571786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of palliative gastrectomy in patients with incurable advanced gastric cancer.
    Kunisaki C; Makino H; Takagawa R; Oshima T; Nagano Y; Fujii S; Otsuka Y; Akiyama H; Ono HA; Kosaka T; Ichikawa Y; Shimada H
    Anticancer Res; 2008; 28(2B):1309-15. PubMed ID: 18505071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multivariate prognostic study on large gastric cancer.
    Shiraishi N; Sato K; Yasuda K; Inomata M; Kitano S
    J Surg Oncol; 2007 Jul; 96(1):14-8. PubMed ID: 17582596
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
    Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
    Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lymphatic advancement to peritoneal dissemination and liver metastasis in gastric cancer patients.
    Maehara Y; Tomisaki S; Oda S; Sakaguchi Y; Ichiyoshi Y; Sugimachi K
    Anticancer Res; 1994; 14(6B):2755-7. PubMed ID: 7872713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. P53 protein expression in gastric adenocarcinoma. Negative predictor of survival after postoperative adjuvant chemotherapy.
    Díez M; Medrano MJ; Gutierrez A; López A; Mugüerza JM; Hernández P; Lozano O; Noguerales F; Ruíz A; Granell J
    Anticancer Res; 2000; 20(5C):3929-33. PubMed ID: 11268479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gastric cancer with metastases to the distant peritoneum: a 20-year surgical experience.
    Kikuchi S; Arai Y; Morise M; Kobayashi N; Tsukamoto H; Shimao H; Sakakibara Y; Hiki Y; Kakita A
    Hepatogastroenterology; 1998; 45(22):1183-8. PubMed ID: 9756030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Results of resection of gastric cancer with distant metastases.
    Kikuchi S; Tsukamoto H; Mieno H; Sato K; Kobayashi N; Shimao H; Sakakibara Y; Hiki Y; Kakita A
    Hepatogastroenterology; 1998; 45(20):592-6. PubMed ID: 9638458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of paraaortic lymph node dissection for advanced gastric cancer.
    Isozaki H; Okajima K; Fujii K; Nomura E; Izumi N; Mabuchi H; Nakamura M; Hara H
    Hepatogastroenterology; 1999; 46(25):549-54. PubMed ID: 10228860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of extended lymphadenectomy in the noncurative gastrectomy for advanced gastric cancer.
    Hanazaki K; Sodeyama H; Mochizuki Y; Machida T; Yokoyama S; Sode Y; Wakabayashi M; Kawamura N; Miyazaki T; Amano J
    Hepatogastroenterology; 1999; 46(28):2677-82. PubMed ID: 10522064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative intraperitoneal chemotherapy for patients with serosa-infiltrating gastric cancer.
    Yano M; Yasuda T; Fujiwara Y; Takiguchi S; Miyata H; Monden M
    J Surg Oncol; 2004 Oct; 88(1):39-43. PubMed ID: 15384086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Post-operative chemotherapy in non-curative gastrectomy for advanced gastric cancer.
    Hanazaki K; Mochizuki Y; Machida T; Yokoyama S; Sodeyama H; Sode Y; Wakabayashi M; Kawamura N; Miyazaki T
    Hepatogastroenterology; 1999; 46(26):1238-43. PubMed ID: 10370699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Surgical treatment and prognosis analysis for patients with gastric cancer infiltrating esophagus].
    Han FH; Zhan WH; He YL; Li YM; Zheng ZQ; Peng JS; Cai SR; Ma JP
    Zhonghua Wei Chang Wai Ke Za Zhi; 2005 May; 8(3):199-202. PubMed ID: 16167226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regional lymph node metastasis as a predictor of peritoneal carcinomatosis in patients with Borrmann type IV gastric carcinoma.
    Otsuji E; Yamaguchi T; Sawai K; Sakakura C; Okamoto K; Takahashi T
    Am J Gastroenterol; 1999 Feb; 94(2):434-7. PubMed ID: 10022642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strong association of lymph node metastasis with intraperitoneal free cancer cell (IFCC) in advanced gastric cancer.
    Yamashita K; Sakuramoto S; Kikuchi S; Katada N; Kobayashi N; Watanabe M
    Hepatogastroenterology; 2008; 55(86-87):1873-7. PubMed ID: 19102412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic factors and rational approach in the treatment of submucosal cancer of the stomach.
    Kubota H; Tabara H; Kotoh T; Kumar DD; Monden N; Watanabe R; Kohno H; Nagasue N
    J Surg Res; 1998 Dec; 80(2):304-8. PubMed ID: 9878329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation of the histological effects and survival after neoadjuvant chemotherapy on gastric cancer patients.
    Yonemura Y; Kinoshita K; Fujimura T; Fushida S; Sawa T; Matsuki N; Tanaka S; Kamata T; Takashima T; Miyazaki I
    Hepatogastroenterology; 1996; 43(11):1260-72. PubMed ID: 8908561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.